5 Results for "

mEH inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "mEH inhibitor" in MCE Product Catalog:

Cat. No.: HY-146696
CAS No.: 2418576-06-2
Purity:  ≥98.0%
mEH-IN-1 (Compound 62) is a potent microsomal epoxide hydrolase (mEH) inhibitor with the IC50 of 2.2 nM. The mEH is a mammalian α/β-fold hydrolase enzyme, expressed in almost all tissues, hydrolyzes a wide range of epoxide containing molecules. The mEH is mainly localized in the endoplasmic reticulum (ER) of eukaryotic cells. mEH-IN-1 can be used for the research of preeclampsia, hypercholanemia and cancer .
loading...
    loading...
Cat. No.: HY-120137
CAS No.: 880813-42-3
Purity:  99.02%
Research Areas:  

Cancer

CMP-5 is a potent, specific, and selective PRMT5 inhibitor, while displays no activity against PRMT1, PRMT4, and PRMT7 enzymes. CMP-5 selectively blocks S2Me-H4R3 by inhibiting PRMT5 methyltransferase activity on histone preparations. CMP-5 prevents Epstein-Barr virus (EBV)-driven B-lymphocyte transformation but leaving normal B cells unaffected .
loading...
    loading...
Cat. No.: HY-W101419
CAS No.: 59512-17-3
Target:  

Epoxide Hydrolase

Research Areas:  

Cardiovascular Disease Cancer

Ibuprofenamide (Compound 136) is a potent microsomal epoxide hydrolase (mEH) inhibitor with an IC50 value of 96 μM. Ibuprofenamide is promising for research of preeclampsia, hypercholanemia and cancer .
loading...
    loading...
Cat. No.: HY-113846
CAS No.: 1030021-40-9
Research Areas:  

Cancer

CMP-5 hydrochloride is a potent, specific, and selective PRMT5 inhibitor, while displays no activity against PRMT1, PRMT4, and PRMT7 enzymes. CMP-5 hydrochloride selectively blocks S2Me-H4R3 by inhibiting PRMT5 methyltransferase activity on histone preparations. CMP-5 hydrochloride prevents EBV-driven B-lymphocyte transformation but leaving normal B cells unaffected .
loading...
    loading...
Cat. No.: HY-113846A
CAS No.: 2309409-79-6
Research Areas:  

Cancer

CMP-5 dihydrochloride is a potent, specific, and selective PRMT5 inhibitor, while displays no activity against PRMT1, PRMT4, and PRMT7 enzymes. CMP-5 dihydrochloride selectively blocks S2Me-H4R3 by inhibiting PRMT5 methyltransferase activity on histone preparations. CMP-5 dihydrochloride prevents EBV-driven B-lymphocyte transformation but leaving normal B cells unaffected .
loading...
    loading...